source
- Deloitte urges advanced therapy makers to adopt AI-driven digital staff to overcome operational bandwidth limitsAdvanced therapy manufacturers are confronting an operational bottleneck as their pipelines expand rapidly. More than a thousand advanced therapies are in development and the U.S. patient pool is e…
- FDA clears Abbott’s Libre Duo 10-Day sensor to warn of diabetic ketoacidosisThe U.S. Food and Drug Administration has cleared Abbott’s new wearable device that measures both glucose and ketone levels in people with diabetes. The clearance allows the product to be marketed…